DUCHENNE MUSCULAR DYSTROPHY (DMD)
Clinical trials for DUCHENNE MUSCULAR DYSTROPHY (DMD) explained in plain language.
Never miss a new study
Get alerted when new DUCHENNE MUSCULAR DYSTROPHY (DMD) trials appear
Sign up with your email to follow new studies for DUCHENNE MUSCULAR DYSTROPHY (DMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for DMD: Long-Term drug trial aims to preserve muscle function
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a weekly IV drug called BMN 351 in people with Duchenne muscular dystrophy (DMD) whose genetic makeup allows for exon 51 skipping. Participants must have completed a prior study of the same drug. The goal is to see if the dr…
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New hope for DMD: extended trial tests Muscle-Strengthening drug over 12 months
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a daily pill called SAT-3247 in people with Duchenne muscular dystrophy (DMD) who have already taken it in a previous study. Up to 10 participants will take the drug for 11 more months (12 months total) to see if it helps ma…
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New hope for duchenne boys: experimental drug RAG-18 enters human testing
Disease control OngoingThis early-stage study tests the safety of a new drug, RAG-18, in 12 boys aged 4-15 with Duchenne muscular dystrophy. The drug is given through a vein, and researchers will check for side effects, how the body processes the drug, and whether it helps slow muscle damage. The goal …
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Walking and counting: new training aims to boost brain and body in DMD boys
Symptom relief ENROLLING_BY_INVITATIONThis study tests an 8-week dual-tasking program for 16 boys aged 6–12 with Duchenne muscular dystrophy. The program combines physical and mental exercises, like walking while counting backward, to improve coordination, thinking, and daily living skills. Participants are randomly …
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Phase: NA • Sponsor: Lokman Hekim University • Aim: Symptom relief
Last updated May 26, 2026 07:54 UTC
-
VR game aims to make rehab fun for kids with muscle disease
Symptom relief ENROLLING_BY_INVITATIONThis study is testing a virtual reality game designed specifically for people with Duchenne muscular dystrophy. Six participants will play the game once using a VR headset and hand tracking. Researchers will measure how easy and enjoyable the game is, and whether it causes any di…
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Sponsor: Istanbul University • Aim: Symptom relief
Last updated May 26, 2026 07:50 UTC
-
Ear-Zap device could replace harsh steroids for kids with muscle disease
Symptom relief ENROLLING_BY_INVITATIONThis study tests a small device worn on the ear that sends gentle electrical pulses to the vagus nerve, aiming to safely reduce inflammation in children with Duchenne muscular dystrophy (DMD). Twenty boys aged 5–17 will use the device at home for one week. The goal is to see if t…
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Phase: NA • Sponsor: taVNS AB • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
New study probes muscle changes in duchenne patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how muscles in the arms and shoulders change in people with Duchenne muscular dystrophy (DMD). Researchers will measure muscle stiffness, tone, and strength using a special device and simple tests. The goal is to better understand muscle health and help improv…
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Sponsor: Sanko University • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
First step toward duchenne treatment: drug safety check in healthy volunteers
Knowledge-focused OngoingThis early-stage trial tests the safety and how the body handles a new drug called GRT6019 in 24 healthy men. The drug is being developed for Duchenne muscular dystrophy, but this study only checks for side effects and drug levels in the blood. Participants take the drug for 4 we…
Matched conditions: DUCHENNE MUSCULAR DYSTROPHY (DMD)
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC